These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 1418068

  • 1. Platelet-activating factor antagonists in experimental shock.
    Muacevic G, Heuer HO.
    Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
    [Abstract] [Full Text] [Related]

  • 2. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
    Bouvier C, Guc MO, Furman BL, Parratt JR.
    Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis.
    Sakuma Y, Shirato M, Nagaoka J, Obaishi H, Tsunoda H, Katayama S, Ono H, Katayama K.
    Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW.
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
    Heuer HO, Letts G, Meade CJ.
    J Lipid Mediat; 1990 Jan; 2 Suppl():S101-8. PubMed ID: 2133276
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J, Muacevic G, Weber KH.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
    Natsume Y, Imanishi N, Koike H, Morooka S.
    Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
    [Abstract] [Full Text] [Related]

  • 19. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
    Salari H, Demos M, Wong A.
    Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.